Posizioni attive di Bradford C. Sippy
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Tremeau Pharmaceuticals, Inc.
 Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA. | Direttore/Membro del Consiglio | 01/07/2016 | - |
| Amministratore Delegato | 01/07/2016 | - | |
| Fondatore | 01/07/2016 | - | |
Lennham Pharmaceuticals, Inc.
 Lennham Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lennham Pharmaceuticals, Inc. develops pharmaceutical products. The CEO of the American company is Bradford C. Sippy. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | - | - |
Storia della carriera di Bradford C. Sippy
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Tremeau Pharmaceuticals, Inc.
Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA. | Health Technology |
Lennham Pharmaceuticals, Inc.
Lennham Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lennham Pharmaceuticals, Inc. develops pharmaceutical products. The CEO of the American company is Bradford C. Sippy. | Health Technology |
- Borsa valori
- Insiders
- Bradford C. Sippy
- Esperienza
